Potential side effects are minimal in studies, but include mild gastrointestinal issues
What that looks like in practice: some people notice shifts in energy and how their body composition responds before the scale moves much, since the goal is metabolic, not just water weight
Preliminary studies suggest potential associations between 5-Amino-1MQ and mitochondrial outcomes, including investigations of biogenesis and cellular energy-related mechanisms
Most people get enough vitamin B12 from their diet, but some people have a deficiency
In clinical use, significant side effects are uncommon, and the vast majority of patients tolerate the therapy without problems
NMN and NR have longer safety track records in humans (trials up to 12 months), whereas 5-Amino-1MQ data stops at 12 weeks